MarketPeel
Insider Trading Intelligence
HM

Heather Ann Mcsharry

JAZZ
DIRECTOR · JAZZ PHARMACEUTICALS PLC · CIK 0001576068
FILING MIX · LIFETIME45%/55%
BUYS
9
SELLS
11
TOTAL VALUE
$3.95M
COMPANIES
1
ACTIVE SINCE
Aug 2020
HOLDINGS NOW
18,449
AVG SELL PX
$156.37
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Heather Ann Mcsharry, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%+1.24%+2.11%-0.87%+0.15%
14d5+40.00%-0.23%+1.06%-1.29%+2.05%
30d5+80.00%-1.49%-0.21%-1.28%+2.07%
60d5+80.00%-4.87%-4.52%-0.35%-0.09%
90d5+80.00%-1.45%-1.28%-0.17%+1.95%
180d5+20.00%+9.04%+8.59%+0.45%+0.28%
1y5(1 pending)+75.00%-7.40%+19.44%-26.84%-24.63%
2y5(1 pending)+75.00%-12.11%+33.30%-45.41%-56.59%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
JAZZ · 18,449 shares · as of May 22, 2026
05,96611,93217,89823,864202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 11 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
2,000$241.00$482.0K18,449May 22, 2026May 27, 2026View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASE
3,415$138.08$471.5K23,864Nov 20, 2025Nov 24, 2025View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
3,4150Nov 20, 2025Nov 24, 2025View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
3,415$177.78$607.1K20,449Nov 20, 2025Nov 24, 2025View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,959$111.25$217.9K20,449Aug 8, 2025Aug 11, 2025View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,50722,408Aug 7, 2025Aug 11, 2025View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,608$111.35$179.1K18,901Aug 6, 2024Aug 6, 2024View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,73120,509Aug 2, 2024Aug 6, 2024View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,344$138.16$185.7K16,778Aug 14, 2023Aug 15, 2023View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
3,07518,122Aug 11, 2023Aug 15, 2023View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
5,500$154.59$850.3K15,047Aug 8, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASE
8,000$55.28$442.2K20,547Aug 8, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,179$152.32$179.6K12,547Aug 8, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
8,0000Aug 8, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,56113,726Aug 5, 2022Aug 9, 2022View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,414$147.96$209.2K11,165Aug 6, 2021Aug 10, 2021View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,24612,579Jul 29, 2021Aug 2, 2021View →
JAZZ
JAZZ PHARMACEUTICALS PLC
SALE
1,009$125.87$127.0K10,333Aug 7, 2020Aug 10, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
2,70511,342Aug 6, 2020Aug 10, 2020View →
JAZZ
JAZZ PHARMACEUTICALS PLC
PURCHASEGRANT
Stock grant
6,7656,765Aug 6, 2020Aug 10, 2020View →
Other insiders · JAZZ
Loading peer insiders…
About this filer
CIK 0001576068
ROLE
Director
PRIMARY
JAZZ
COMPANIES
1
ACTIVE SINCE
Aug 2020
MARKETPEEL · /INSIDER/0001576068DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback